Noreta Family Medicine
MAY 21, 2024
Learn CPR! I recently organized several CPR classes for Noreta Family Medicine patients as well as their family and friends. Damar Hamlin’s collapse during an NFL game in January 2023 inspired me to want to hold these CPR classes (although I admit it took a while to arrange!). It was the immediate on-field medical attention that Damar Hamlin received that saved his life, and that is no exaggeration.
FDA Law Blog
MAY 13, 2024
By Jeffrey N. Gibbs & Ana Loloei & Véronique Li, Senior Medical Device Regulation Expert — FDA has long touted the use of real-world evidence ( RWE ). Extolling RWE, FDA has said “RWE can be leveraged to bring new products to market, evaluate the safety and effectiveness of existing products for new uses, and assess the continued performance and safety of products once on the market.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Clinical Problem Solvers
MAY 15, 2024
[link] In this episode of WDx, Dr Nidhi Patel joins Jane, Kaylin, and Sharmin and presents a case of a 23 yr old woman with worsening dyspnea and orthopnea. Screenshot Nidhi is a current CPSolvers Academy member and a PGY2 in internal medicine at Emory University. She grew up in South Florida and went to University of Miami for undergrad and for medical school.
33 Charts
MAY 30, 2024
For most of history, medical diagnosis came through a series of chaotic steps. Patients experienced a string of studies, samples, and images coupled with a doctor’s judgment offering a best-guess answer. Or, in many cases, just a guess. Increasingly, diagnosis is being be reduced to simple transactions. Clean point-of-care testing based on molecular and marker diagnosis.
PEMBlog
MAY 16, 2024
Racepinephrine (Racemic epinephrine) is used for croup patients who have stridor at rest and post extubation stridor. It is currently on national shortage and many facilities have a very limited supply of the nebules on hand. In times of shortage, intravenous EPINEPHRINE 1 mg/mL can be utilized as a nebulized solution in place of racepinephrine using the dosing of 0.5 mg/kg to a max of 5 mg.
LeverageRx
MAY 30, 2024
With physician mortgages, medical professionals get to avoid both a down payment and PMI requirement costs.
Clinical Correlations
MAY 1, 2024
By Alison Cline Peer Reviewed Let’s Start with a Case… A 79-year-old man with a history of atrial fibrillation and stroke presents to the emergency department with new focal neurologic deficits in the setting of a recent upper.
Primary Care Digest brings together the best content for architecture professionals from the widest variety of industry thought leaders.
The Clinical Problem Solvers
MAY 1, 2024
[link] Maddy , Jack, and Sharmin share their approach to focal splenic lesions and splenic infarcts as they discuss a case presented by Youssef. Frameworks Discussed in Case: Focal Splenic Lesion Splenic Infarct Splenic Infarct vs Abscess To join us live on Virtual Morning Report (VMR), sign up HERE.
Evergreen Family Medicine
MAY 31, 2024
The perfect partnershipCraig Underwood (81) is a 4th generation California farmer in Ventura County who was facing headwinds keeping his family farm going. The conventional vegetable farming landscape was changing, profits were less, and he was struggling to survive. A seed supplier mentioned to him a guy pounding the pavement looking for peppers for chili sauce in LA.
PEMBlog
MAY 27, 2024
What if a boy band from the year 2000 wrote a song about he management of status asthmaticus and then someone made a video and then posted that video to a Pediatric Emergency Medicine blog. You’d think that would be pretty silly right? Lyrics Difficulty breathing, asthma’s bad tonight albuterol and atrovent Dexamethasone All right! Magnesium infusion Terb and ketamine If you need that bipap It’s the worst you’ve seen [Chorus] Status!
LeverageRx
MAY 16, 2024
Younger and healthier physicians typically pay less for disability insurance. When you buy a policy at a younger age, your rates stay low.
Vascular Physician
MAY 6, 2024
Everyone in the office provided stellar care!? They're all very caring yet professionals. They're excellent in what they do. I'm so excited to have found someone who is actually able to provide help for my legs.
FDA Law Blog
MAY 30, 2024
By Sophia R. Gaulkin & Alan M. Kirschenbaum — Last week, the United States Court of Appeals for the District of Columbia ruled that Section 340B of the Public Health Service Act does not prohibit pharmaceutical manufacturers from imposing conditions on the distribution of discounted drugs to covered entities in the program. In United Therapeutics Corporation v.
The Clinical Problem Solvers
MAY 8, 2024
[link] In this rheumatology Rafael Medina Subspecialty episode, Dr. Appledene Osbourne presents a case of polyarticular joint pain to Dr. Lianne Gensler. Session facilitator: Maddy Conte The goal of this series is to expand access to subspecialty, primary care, and internal medicine-adjacent specialty education to learners around the world. If you would like to get involved as a case presenter or discussant (or nominate an attending/educator), fill out the form HERE.
Evergreen Family Medicine
MAY 1, 2024
It’s easier to fool people than to convince them that they have been fooled.Mark Twain It is fitting that my final installment of this series has its focus on the last word of my title. Me. Pointing out corruption, financial or political influence, and bias arising from self-interest of corporations, institutions, and journals is important and true.
PEMBlog
MAY 20, 2024
Lyme disease has 3 stages. I have a hard time remembering them. Perhaps some pop punk will help? Learn about Early, Early disseminated, and Late Lyme. And remember, It’s Doxycycline Time! Lyrics [Chorus] Tick, Tick, Tick, Tick, BOOM! It’s Lyme! Doxycycline Time! Tick, Tick, Tick, Tick, BOOM! [Verse] Early disease is just one E M lesion Maybe one tick bite in the warm season Early disseminated is worse, I’ll confide this More rash, neuro stuff, and carditis Late disease joints r
LeverageRx
MAY 16, 2024
Residents, being at the early stages of their medical career, have the ability to earn a high income for the rest of their career.
GeriPal
MAY 9, 2024
Summary Transcript Summary On today’s podcast, we’ve invited four hospice and palliative care social media influencers (yes, that’s a thing!), all of whom focus their efforts on educating the general public about living and dying with a serious illness. Their work is pretty impressive in both reach (some of their posts are seen by millions of viewers) and breadth of work.
FDA Law Blog
MAY 27, 2024
Hyman, Phelps & McNamara, P.C. (HPM) proudly announces the return of Jennifer Newberger as a Director, further boosting its already robust medical device practice. Jennifer’s combination of experiences as in-house counsel for both large and start-up companies as well as outside counsel provides clients invaluable expertise and problem-solving skills.
The Clinical Problem Solvers
MAY 23, 2024
[link] In this episode, the team from The CPSolvers Academy participated in a fantastic discussion. Nidhi presented a case to Mark, Noah, & Yazmin. Embark on this diagnostic journey with us!
FDA Law Blog
MAY 22, 2024
By Jeffrey N. Gibbs & Ana Loloei & Véronique Li, Senior Medical Device Regulation Expert — We recently blogged about the Center for Devices and Radiological Health’s (CDRH) reluctance to make full use of real-world data (RWD) and real-world evidence (RWE) to support marketing applications. In response to the post, we did receive feedback from a company that had had the good fortune to have very positive experiences with RWD/RWE.
FDA Law Blog
MAY 19, 2024
By Sarah Wicks — On May 21, 2024, the EveryLife Foundation for Rare Diseases (ELF) will host a Scientific Workshop at the National Press Club in Washington, D.C. aimed at identifying and characterizing the challenges in developing therapies for ultra-rare diseases and conditions that affect exceedingly small populations. The workshop will drive in-depth discussions from leaders across federal agencies, the patient advocacy community, industry, academia and policy to examine the current state of
FDA Law Blog
MAY 15, 2024
On April 29, the FDA issued their long-awaited, controversial Final Rule governing the oversight of laboratory developed tests ( LDTs ). This new rule will dramatically alter the LDT regulatory landscape, while at the same time requiring significant operational changes and posing strategic challenges for many LDTs. The final rule also created exemptions for some other LDTs.
PEMBlog
MAY 13, 2024
Hyperpronation is better than supination-flexion for Nursemaid’s Elbow reduction. Also they call it pulled elbow in Australia. Which is a better name. Swiftly listen to this brief educational song. Lyrics subluxation of the annular ligament about the radial head it’s called a nursemaids elbow, I know you’re well read there’s a couple maneuvers that will make it all better hyperpronation is best, there’s no need to fret sir [Chorus] hello nursemaid’s my old fr
LeverageRx
MAY 9, 2024
FNBO provides flexible credit and income qualifications that help professionals achieve find the perfect loan.
PEMBlog
MAY 6, 2024
Simple febrile seizures are scary for parents – but all that is really needed is reassurance and education. Lyrics Febrile seizures, you’re warm and you’re shaking Not like a teen who’s convulsing and faking The fever spikes, unconscious and stiff tonic and clonic it’s over in a jiff Simple febrile seizures they may seem scary, Parents are trembling worried and wary they’re self limited and stop on their own all you need is reassurance and discharge home This
FDA Law Blog
MAY 1, 2024
Hyman, Phelps & McNamara, P.C. proudly announces the return of attorney Sarah Wicks to its drug development and compliance group. Sarah brings a wealth of experience and a proven track record of advising innovative drug and biologics companies through the intricate landscape of product development and commercialization. Her expertise spans a range of critical areas including: human subject protections, clinical trial conduct, development strategies, FDA interactions, and enforcement action r
The Clinical Problem Solvers
MAY 30, 2024
[link] Episode description: SLS team members Mukund, Jasdeep and Valeria discuss a case of a second-trimester primigravida with new headache. Featuring: Mukund Raguram Jasdeep Bajwa Valeria Roldan Schemas Secondary Headache CSF Lymphocytic Pleocytosis Download CPSolvers App here RLRCPSOLVERS Click here to view the weekly episode recap email!
The Clinical Problem Solvers
MAY 7, 2024
[link] Title Progressive back pain Episode description Reza and Rabih discuss a case of a patient with back pain Student discount [link] IMG discount Use coupon code RLRIMG at check out [link]
The Clinical Problem Solvers
MAY 4, 2024
Spaced Learning Resources This is a CPS x Glass Health account created to help you DIGEST the wonderful content crafted by the CPSolvers team across all our platforms. This contains curated pearls from previous VMRs, thought-provoking podcast reviews, and insightful infographics. Reasoning Rendezvous is a quarterly blog series focused on highlighting the experiences of learners and educators of clinical reasoning around the world.
FDA Law Blog
MAY 5, 2024
By Larry K. Houck — The Associated Press reported on Tuesday following confirmation by five anonymous individuals with knowledge that the Drug Enforcement Administration (“DEA”) is moving to reschedule marijuana from schedule I to the less stringently controlled schedule III. US poised to ease restrictions on marijuana in historic shift, but it’ll remain controlled substance (Apr. 30, 2024).
FDA Law Blog
MAY 16, 2024
By Larry K. Houck — Employee diversion of controlled substances from hospitals has been an issue since at least 1986 when I became a diversion investigator with the Drug Enforcement Administration (“DEA”). But there has been a recent string of large civil monetary settlements, some in the millions of dollars, to resolve allegations that hospitals’ non-compliance with the federal Controlled Substances Act (“CSA”) and DEA regulations allowed employees to divert staggering quantities of controlled
FDA Law Blog
MAY 23, 2024
By Steven J. Gonzalez — On May 15th and 16th, respectively, Senator Rand Paul and Congressmen Brad Finstad and Dan Crenshaw introduced Senate and House resolutions “providing for congressional disapproval under chapter 8 of title 5, United States Code” of FDA’s Final Rule to regulate Laboratory Developed Tests (LDTs). These resolutions are the first step in the (unlikely) process to repeal FDA’s Final Rule using the Congressional Review Act (CRA).
LeverageRx
MAY 30, 2024
BMO Harris Bank offers physician mortgage loans for medical professionals. Click to find out more about the details and benefits.
LeverageRx
MAY 30, 2024
BMO Harris Bank offers physician mortgage loans for medical professionals. Click to find out more about the details and benefits.
LeverageRx
MAY 14, 2024
BMO Harris Bank offers physician mortgage loans for medical professionals. Click to find out more about the details and benefits.
FDA Law Blog
MAY 21, 2024
By Larry K. Houck — Last August Health and Human Services (“HHS”) recommended rescheduling marijuana from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. We wondered how given that HHS and the Drug Enforcement Administration (“DEA”) conducted eight-factor scheduling analyses in 2016, concluding that there was “no substantial evidence that marijuana should be removed from Schedule I.
Expert insights. Personalized for you.
52 
Let's personalize your content